0.64
-0.0213(-3.23%)
Currency In USD
| Previous Close | 0.66 |
| Open | 0.68 |
| Day High | 0.68 |
| Day Low | 0.63 |
| 52-Week High | 1.49 |
| 52-Week Low | 0.63 |
| Volume | 461,659 |
| Average Volume | 424,801 |
| Market Cap | 26.78M |
| PE | -1.6 |
| EPS | -0.4 |
| Moving Average 50 Days | 0.88 |
| Moving Average 200 Days | 0.9 |
| Change | -0.02 |
If you invested $1000 in SCYNEXIS, Inc. (SCYX) 10 years ago, it would be worth $9.98 as of November 04, 2025 at a share price of $0.639. Whereas If you bought $1000 worth of SCYNEXIS, Inc. (SCYX) shares 5 years ago, it would be worth $142.57 as of November 04, 2025 at a share price of $0.639.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study
GlobeNewswire Inc.
Oct 15, 2025 12:00 PM GMT
SCYNEXIS to receive a $22 million payment as part of the resolution related to the restart of the Phase 3 MARIO study on invasive candidiasisScynexis will promptly wind-down and terminate the MARIO studyThe payment from GSK, combined with cash in han
SCYNEXIS Announces Positive Results from a Phase 1, Single Ascending Dose and Multiple Ascending Dose Study of its Second-Generation Fungerp (SCY-247)
GlobeNewswire Inc.
Sep 30, 2025 12:00 PM GMT
No safety concerns or dose limiting toxicities observed SCY-247 was able to achieve target exposures at doses lower than our first-generation fungerp Safety, tolerability, and pharmacokinetic profile support the continued clinical development of SCY-
SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)
GlobeNewswire Inc.
Sep 04, 2025 12:30 PM GMT
Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated with echinocandin-resistanceAdditional poster presentations highlight SCY-247’s broad spectrum